Home › Bladder Cancer › Michigan › Livonia
Bladder Cancer clinical trials in Livonia, MI
4 studies for Bladder Cancer are looking for participants at sites in and around Livonia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Henry Ford Medical Center - Livonia, Livonia
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecruitingPhase 2
- Trinity Health Saint Mary Mercy Livonia Hospital, Livonia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Trinity Health Saint Mary Mercy Livonia Hospital, Livonia
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Trinity Health Saint Mary Mercy Livonia Hospital, Livonia
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Houston, TX31 studies
- Nashville, TN31 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Boston, MA26 studies
- Baltimore, MD24 studies
- Los Angeles, CA24 studies
- St. Louis, MO22 studies
- Seattle, WA21 studies
- Philadelphia, PA21 studies
- Edison, NJ21 studies
Other studies in Livonia
- Lung Cancer10 studies
- Non-Small Cell Lung Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Prostate Cancer7 studies
- Colorectal Cancer6 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Ovarian Cancer4 studies
- Breast Cancer4 studies
- Multiple Myeloma3 studies
- Esophageal Cancer3 studies
- Stomach Cancer3 studies
- Pancreatic Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.